Central Nervous System (CNS) Lesions
1 clinical trials · Condition
◉ Watch Central Nervous System (CNS) Lesions
| Record | Firm | Date |
|---|---|---|
| Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent (NCT06322342) | Reveal Pharmaceuticals Inc. | 2024-08-15 |
Track Central Nervous System (CNS) Lesions automatically
Every clearance here is in the API, with alerts when new ones post.